首页> Expert opinion on drug discovery> Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

导出原文传递

翻译打印收藏纠错

第一作者： Matthews,T.P.

作者： Matthews,T.P. ^[1] ; Jones,A.M. ; Collins,I.

作者单位： Institute of Cancer Research, Cancer Research UK Cancer Therapeutics Unit, London SM2 5NG, United ^[1]

关键词 Cancer Cell-cycle checkpoint DNA damage Kinase inhibitor Structure-based drug design

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert opinion on drug discovery

2013年8卷6期

621-640页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Expert opinion on drug discovery

2013年8卷6期

621-640页

检索历史清除

Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

Expert opinion on drug discovery

相似文献

同项目论文

Expert opinion on drug discovery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

Expert opinion on drug discovery

相似文献

同项目论文

Expert opinion on drug discovery

相关期刊

检索历史清除